Horm Metab Res 1992; 24(6): 258-262
DOI: 10.1055/s-2007-1003308
Originals Basic
© Georg Thieme Verlag, Stuttgart · New York

Increased Ketogenesis Related to Insulin Deficiency in Isolated Hepatocytes from NIDDM Model Rats

T. Aoki1 , H. Hidaka1 , K. Kosugi1 , H. Kojima1 , Y. Nakajima1 , T. Nakamura1 , Y. Harano2 , Y. Shigeta1
  • 1Third Department of Medicine, Shiga University of Medical Science, Ohtsu, Shiga, Japan
  • 2Department of Atherosclerosis and Metabolism, National Cardiovascular Center Hospital, Suita, Osaka, Japan
Further Information

Publication History

1991

1991

Publication Date:
14 March 2008 (online)

Summary

To investigate the hepatic ketone body metabolism in NIDDM, we studied the ketone body production rates in hepatocytes from newly developed non-obese NIDDM model rats. NIDDM model rats were prepared by intraperitoneal injection of streptozotocin at 2 or 5 days of age (STZ 2, STZ 5 respectively). After 10-15 weeks, ketone body production rates in hepatocytes isolated from these rats were compared with those from control rats as well as ketotic rats made by intravenous injection of streptozotocin into adult rats. Basal ketone body production rates from 0.3 mM [U-14C] palmitate in hepatocytes from control, STZ 2, STZ 5 and ketotic rats were 11.7±0.98, 14.9±0.72, 16.0±0.45, 22.8±2.32 nmole · palmitate/mg · prot/hr, respectively. These rates were stimulated by 1 μg/ml of glucagon in control, STZ 2 and STZ 5 rats (14.1±0.99, 18.6±1.36, 18.7±0.69 nmole·palmitate/mg·prot/hr, respectively), but not in ketotic rats (22.8±2.07 nmole · palmitate/mg · prot/hr). The similar effects were observed by 1 μg/ml of epinephrine. The basal ketone body production rates were negatively correlated to both hepatic glycogen contents and plasma IRI levels. Considering these parameters together, the extent of metabolic derangement in STZ 2 and STZ 5 rats was between that in control and ketotic rats. These results indicate that the derangements of hepatic ketone body production are related to the severity of insulin deficiency and suggest that the enhanced hepatic ketogenesis contributes in part to the elevated plasma ketone body levels in non-obese NIDDM.